Christal Worthen

Christal Worthen

Auto-generated profile, based on publicly available information

Christal Worthen

Department of Dermatology University of Michigan Medical School Ann Arbor Michigan USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2014 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CWChristal A. Worthen
Christal A. Worthen
CECaroline Enns
Caroline Enns
Fine tuning of body iron is required to prevent diseases such as iron-overload and anemia. The putative iron-sensor, transferrin receptor 2 (TfR2), is expressed in the liver and mutations in this protein result in the iron-overload disease Type III hereditary hemochromatosis (HH). With the loss of functional TfR2, the liver produces about two-fold less of the peptide hormone hepcidin, which is responsible for negatively regulating iron uptake from the diet. This reduction in hepcidin expression leads to the slow accumulation of iron in the liver, heart, joints, and pancreas and subsequent cirrhosis, heart disease, arthritis, and diabetes. TfR2 can bind iron-loaded transferrin in the bloodstream, and hepatocytes treated with transferrin respond with a two-fold increase in hepcidin expression through stimulation of the BMP-signaling pathway. Loss of functional TfR2 or its binding partner, the original HH protein (HFE), results in a loss of this transferrin-sensitivity. While much is known about the trafficking and regulation of TfR2, the mechanism of its transferrin-sensitivity through the BMP-signaling pathway is still not known.

11 May 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CWChristal A. Worthen
Christal A. Worthen
YCYilei Cui
Yilei Cui
JOJeffrey S. Orringer
Jeffrey S. Orringer
TJTimothy M. Johnson
Timothy M. Johnson
JVJohn J. Voorhees
John J. Voorhees
GFGary Fisher
Gary Fisher

9 June 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
NZNingning Zhao
Ningning Zhao
AZAn-Sheng Zhang
An-Sheng Zhang
CWChristal Worthen
Christal Worthen
MKMitchell D. Knutson
Mitchell D. Knutson
CECaroline Enns
Caroline Enns
Protein degradation is instrumental in regulating cellular function. Plasma membrane proteins targeted for degradation are internalized and sorted to multivesicular bodies, which fuse with lysosomes, where they are degraded. ZIP14 is a newly identified iron transporter with multitransmembrane domains. In an attempt to dissect the molecular mechanisms by which iron regulates ZIP14 levels, we found that ZIP14 is endocytosed, extracted from membranes, deglycosylated, and degraded by proteasomes. This pathway did not depend on the retrograde trafficking to the endoplasmic reticulum and thus did not involve the well-defined endoplasmic reticulum-associated protein degradation pathway. Iron inhibited membrane extraction of internalized ZIP14, resulting in higher steady-state levels of ZIP14. Asparagine-linked (N-linked) glycosylation of ZIP14, particularly the glycosylation at N102, was required for efficient membrane extraction of ZIP14 and therefore is necessary for its iron sensitivity. These findings highlight the importance of proteasomes in the degradation of endocytosed plasma membrane proteins.

2 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CECaroline Enns
Caroline Enns
RARiffat Ahmed
Riffat Ahmed
JWJiaohong Wang
Jiaohong Wang
AUAkiko Ueno
Akiko Ueno
CWChristal Worthen
Christal Worthen
AZAn-Sheng Zhang
An-Sheng Zhang
Bone morphogenetic protein 6 (BMP6) is an essential cytokine for the expression of hepcidin, an iron regulatory hormone secreted predominantly by hepatocytes. Bmp6 expression is upregulated by increased iron-levels in the liver. Both hepatocytes and non-parenchymal liver cells have detectable Bmp6 mRNA. Here we showed that induction of hepcidin expression in hepatocytes by dietary iron is associated with an elevation of Bmp6 mRNA in the non-parenchymal cells of the liver. Consistently, incubation with iron-saturated transferrin induces Bmp6 mRNA expression in isolated hepatic stellate cells, but not in hepatocytes. These observations suggest an important role of the non-parenchymal liver cells in regulating iron-homeostasis by acting as a source of Bmp6.

4 May 2010 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CWChristal Worthen
Christal Worthen
BJBryan C. Jensen
Bryan C. Jensen
MPMarilyn Parsons
Marilyn Parsons
The options for treating the fatal disease human African trypanosomiasis are limited to a few drugs that are toxic or facing increasing resistance. New drugs that kill the causative agents, subspecies of Trypanosoma brucei, are therefore urgently needed. Little is known about the cellular mechanisms that lead to death of the pathogenic bloodstream stage. We therefore conducted the first side by side comparison of the cellular effects of multiple death inducers that target different systems in bloodstream form parasites, including six drugs (pentamidine, prostaglandin D2, quercetin, etoposide, camptothecin, and a tetrahydroquinoline) and six RNAi knockdowns that target distinct cellular functions. All compounds tested were static at low concentrations and killed at high concentrations. Dead parasites were rapidly quantified by forward and side scatter during flow cytometry, as confirmed by ethidium homodimer and esterase staining, making these assays convenient for quantitating parasite death. The various treatments yielded different combinations of defects in mitochondrial potential, reactive oxygen species, cell cycle, and genome segregation. No evidence was seen for phosphatidylserine exposure, a marker of apoptosis. Reduction in ATP levels lagged behind decreases in live cell number. Even when the impact on growth was similar at 24 hours, drug-treated cells showed dramatic differences in their ability to further proliferate, demonstrating differences in the reversibility of effects induced by the diverse compounds. Parasites showed different phenotypes depending on the treatment, but none of them were clear predictors of whether apparently live cells could go on to proliferate after drugs were removed. We therefore suggest that clonal proliferation assays may be a useful step in selecting anti-trypanosomal compounds for further development. Elucidating the genetic or biochemical events initiated by the compounds with the most profound effects on subsequent proliferation may identify new means to activate death pathways. The parasite Trypanosoma brucei causes human African trypanosomiasis, which is fatal unless treated. Currently used drugs are toxic, difficult to administer, and often are no longer effective due to drug resistance. The search for new drugs is long and expensive, and determining which compounds are worth pursuing is a key challenge in that process. In this study we sought to determine whether different compounds elicited different responses in the mammalian-infective stage of the parasite. We also examined whether genetic knockdown of parasite molecules led to similar responses. Our results show that, depending on the treatment, the replication of the parasite genomes, proper division of the cell, and mitochondrial function can be affected. Surprisingly, these different responses were not able to predict which compounds affected the long term proliferative potential of T. brucei. We found that some of the compounds had irreversible effects on the parasites within one day, so that even cells that appeared healthy could not proliferate. We suggest that determining which compounds set the parasites on a one-way journey to death may provide a means of identifying those that could lead to drugs with high efficacy.

6 October 2026 in Journal of Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
YCYilei Cui
Yilei Cui
MSMai Shi
Mai Shi
CWChristal Worthen
Christal Worthen
SGSherilyn Grill
Sherilyn Grill
JNJayakrishnan Nandakumar
Jayakrishnan Nandakumar
GFGary Fisher
Gary Fisher
Dermal fibroblasts synthesize, organize, and reside within the dermal extracellular matrix (ECM), which provides mechanical support to the skin and a microenvironment critical for dermal cell function. During aging, the ECM becomes fragmented, a change associated with clinical manifestations such as thin, fragile skin and altered fibroblast function, including reduced expression of ECM structural genes and increased expression of pro‐inflammatory mediators. We investigated whether functional alterations of fibroblasts in aged skin reflect adaptation to the aged dermal ECM microenvironment or intrinsic aging responses. Primary dermal fibroblast cultures were established from young (20–30 years; 6 females, 6 males) and aged (>80 years; 6 females, 6 males) sun‐protected skin. No differences in early growth kinetics were observed between groups; however, fibroblasts from aged individuals grew more slowly after approximately 25 population doublings and had a 20% lower final population doubling level. Prior to passage, after brief primary culture (6–8 days), the average telomere length of fibroblasts from aged donors was reduced by approximately 1000 base pairs (∼1 kb). Global gene expression revealed 477 differentially expressed genes (DEGs; padj ≤0.05, absolute log2FC ≥ 0.58), comprising 300 upregulated and 177 downregulated transcripts. Upregulated DEGs and associated protein–protein interaction networks were enriched in cytokine‐ and chemokine‐mediated signaling pathways ( p < 10 −5 ). Downregulated DEGs were enriched in lipid biosynthesis and fatty acid metabolism. Notably, fibroblasts from young and aged skin expressed similar levels of genes encoding ECM structural proteins, including collagens (42 genes), proteoglycans (29 genes), and glycoproteins (157 genes). These findings indicate that fibroblasts from aged skin retain a pro‐inflammatory transcriptional phenotype in primary culture, resembling their phenotype in vivo. In contrast, primary fibroblasts from aged skin express youthful levels of ECM structural genes in primary culture, suggesting that reduced ECM gene expression in vivo reflects dynamic adaptation to the aged dermal microenvironment rather than permanent reduction of synthetic capacity.